TAT and neoplasm: Here, we have constructed an ELP-based tumor targeting carrier Tat-A1E28 or Tat-A4V48 containing two complementary features, that is, efficient cell penetration and cell type specificity, by incorporating Tat (a CPP) and single or multiple copies of AP1 (an IL-4 receptor specific ligand).